Overview

Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to explore the safety and efficacy of subcutaneous injections of Deoxycholic Acid relative to placebo, in the submental area in patients with mild or extreme fullness of the submental fat and ratings of 1 or 4.
Phase:
Phase 3
Details
Lead Sponsor:
Kythera Biopharmaceuticals
Treatments:
Deoxycholic Acid